UTMD — Utah Medical Products Cashflow Statement
0.000.00%
Last trade - 00:00
- $236.59m
- $143.72m
- $50.22m
- 93
- 60
- 27
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 14.7 | 10.8 | 14.8 | 16.5 | 16.6 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.204 | 0.202 | 0.232 | 0.272 | 0.257 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.32 | 1.99 | -1.01 | -2.23 | -0.233 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 17.1 | 20.1 | 21.2 | 21.1 | 22.3 |
Capital Expenditures | -21.5 | -0.86 | -0.552 | -0.818 | -0.639 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Cash from Investing Activities | -21.5 | -0.86 | -0.552 | -0.818 | -0.639 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -4.23 | -10.7 | -10.9 | -5.48 | -4.17 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -8.32 | 8.8 | 9.38 | 14.1 | 17.8 |